Pfizer, the pharmaceutical company expected to become a $100 billion giant this year thanks to COVID-19 drug and vaccine, has admitted that it actually had no...
Emergence of new SARS-CoV-2 variants may decrease long-term vaccine durability, increasing the risk of infection and hospitalization. However, evidence is limited regarding the vaccine effectiveness of...
Fatigue and headache were the most common symptoms reported by individuals an average of more than four months out from having COVID-19, investigators report.
SARS-CoV-2 mirrors other endemic coronaviruses that also evolve and reinfect us despite natural immunity to earlier strains.
Among individuals diagnosed with covid-19 in 2020, 32% sought medical attention in the post-acute period for one or more new or persistent conditions, which was 11%...
In computer simulations, particles lower than the head and moving toward the ground became caught in each mannequin's wake and moved downward. It appeared particles above...
Neutralization titres for Omicron were boosted following a third dose with AstraZeneca’s COVID-19 vaccine compared to titres after a second dose. The levels seen after the...
Atopic (triggered by allergens) disease, which includes eczema/dermatitis and hay fever/allergic rhinitis, was independently associated with 23% lower odds of developing the infection than it was...
People with diabetes are at higher risk for COVID-19-related complications, especially if they are over the age of 40.
Researchers found that ambient UVB radiation at an individual’s place of residence preceding COVID-19 infection was strongly and inversely associated with hospitalisation and death. This suggests...
